IDH3G Antikörper (C-Term)

Produktnummer ABIN952962

Produktdetails anti-IDH3G Antikörper

Target: IDH3G (Isocitrate Dehydrogenase 3 (NAD+) gamma (IDH3G))

Bindungsspezifität: AA 364-393, C-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser IDH3G Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Flow Cytometry (FACS), Enzyme Immunoassay (EIA)

Spezifität: This antibody recognizes Human Isocitric dehydrogenase gamma / IDH3G (C-term).

Aufreinigung: Protein A column, followed by peptide affinity purification

Immunogen: KLH conjugated synthetic peptide between 364~393 amino acids from the C-terminal region of human IDH3G

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.25 mg/mL

Buffer: PBS containing 0.09 % (W/V) Sodium Azide as preservative

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu IDH3G

Target: IDH3G (Isocitrate Dehydrogenase 3 (NAD+) gamma (IDH3G))

Andere Bezeichnung: Isocitric Dehydrogenase gamma / IDH3G (IDH3G Produkte)

Synonyme: H-IDHG antikoerper, MGC83400 antikoerper, wu:fa01b02 antikoerper, wu:fc88f06 antikoerper, h-idhg antikoerper, IDH antikoerper, isocitrate dehydrogenase 3 (NAD(+)) gamma antikoerper, isocitrate dehydrogenase 3 (NAD+) gamma S homeolog antikoerper, isocitrate dehydrogenase 3 (NAD+) gamma antikoerper, isocitrate dehydrogenase 3 (NAD+), gamma antikoerper, isocitrate dehydrogenase 3 (NAD), gamma antikoerper, IDH3G antikoerper, idh3g.S antikoerper, idh3g antikoerper, Idh3g antikoerper

Hintergrund: Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the gamma subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase. This gene is a candidate gene for periventricular heterotopia.Synonyms: NAD(+)-specific ICDH gamma, mitochondrial Isocitrate dehydrogenase [NAD] subunit gamma

Molekulargewicht: 42794 Da

Gen-ID: 3421

NCBI Accession: NP_004126